Subsequently, the RMSD showed a decreasing trend from 6.5 Å to 4 Å with slight fluctuations up to 90 ns.
← all excerpts
Unveiling potent inhibitors for schistosomiasis through ligand-based drug design, molecular docking, molecular dynamics simulations and pharmacokinetics predictions.
1
—
—